Your browser doesn't support javascript.
loading
Integrated multimodal cell atlas of Alzheimer's disease.
Gabitto, Mariano I; Travaglini, Kyle J; Rachleff, Victoria M; Kaplan, Eitan S; Long, Brian; Ariza, Jeanelle; Ding, Yi; Mahoney, Joseph T; Dee, Nick; Goldy, Jeff; Melief, Erica J; Brouner, Krissy; Campos, John; Carr, Ambrose J; Casper, Tamara; Chakrabarty, Rushil; Clark, Michael; Compos, Jazmin; Cool, Jonah; Valera Cuevas, Nasmil J; Dalley, Rachel; Darvas, Martin; Ding, Song-Lin; Dolbeare, Tim; Mac Donald, Christine L; Egdorf, Tom; Esposito, Luke; Ferrer, Rebecca; Gala, Rohan; Gary, Amanda; Gloe, Jessica; Guilford, Nathan; Guzman, Junitta; Ho, Windy; Jarksy, Tim; Johansen, Nelson; Kalmbach, Brian E; Keene, Lisa M; Khawand, Sarah; Kilgore, Mitch; Kirkland, Amanda; Kunst, Michael; Lee, Brian R; Malone, Jocelin; Maltzer, Zoe; Martin, Naomi; McCue, Rachel; McMillen, Delissa; Meyerdierks, Emma; Meyers, Kelly P.
Afiliación
  • Gabitto MI; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Travaglini KJ; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Rachleff VM; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Kaplan ES; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Long B; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Ariza J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Ding Y; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Mahoney JT; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Dee N; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Goldy J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Melief EJ; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Brouner K; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Campos J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Carr AJ; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Casper T; Chan Zuckerberg Initiative, Redwood City, CA 94063.
  • Chakrabarty R; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Clark M; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Compos J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Cool J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Valera Cuevas NJ; Chan Zuckerberg Initiative, Redwood City, CA 94063.
  • Dalley R; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Darvas M; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Ding SL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Dolbeare T; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Mac Donald CL; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Egdorf T; Department of Neurological Surgery, University of Washington, Seattle, WA 98104.
  • Esposito L; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Ferrer R; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Gala R; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Gary A; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Gloe J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Guilford N; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Guzman J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Ho W; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Jarksy T; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Johansen N; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Kalmbach BE; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Keene LM; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Khawand S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Kilgore M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Kirkland A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Kunst M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104.
  • Lee BR; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Malone J; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Maltzer Z; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Martin N; Allen Institute for Brain Science, Seattle, WA, 98109.
  • McCue R; Allen Institute for Brain Science, Seattle, WA, 98109.
  • McMillen D; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Meyerdierks E; Allen Institute for Brain Science, Seattle, WA, 98109.
  • Meyers KP; Allen Institute for Brain Science, Seattle, WA, 98109.
Res Sq ; 2023 May 23.
Article en En | MEDLINE | ID: mdl-37292694
ABSTRACT
Alzheimer's disease (AD) is the most common cause of dementia in older adults. Neuropathological and imaging studies have demonstrated a progressive and stereotyped accumulation of protein aggregates, but the underlying molecular and cellular mechanisms driving AD progression and vulnerable cell populations affected by disease remain coarsely understood. The current study harnesses single cell and spatial genomics tools and knowledge from the BRAIN Initiative Cell Census Network to understand the impact of disease progression on middle temporal gyrus cell types. We used image-based quantitative neuropathology to place 84 donors spanning the spectrum of AD pathology along a continuous disease pseudoprogression score and multiomic technologies to profile single nuclei from each donor, mapping their transcriptomes, epigenomes, and spatial coordinates to a common cell type reference with unprecedented resolution. Temporal analysis of cell-type proportions indicated an early reduction of Somatostatin-expressing neuronal subtypes and a late decrease of supragranular intratelencephalic-projecting excitatory and Parvalbumin-expressing neurons, with increases in disease-associated microglial and astrocytic states. We found complex gene expression differences, ranging from global to cell type-specific effects. These effects showed different temporal patterns indicating diverse cellular perturbations as a function of disease progression. A subset of donors showed a particularly severe cellular and molecular phenotype, which correlated with steeper cognitive decline. We have created a freely available public resource to explore these data and to accelerate progress in AD research at SEA-AD.org.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2023 Tipo del documento: Article